Atlas Trials

Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome

Clinical trial NCT04346017 · COMPLETED

Trial details

NCT number
NCT04346017
Sponsor
Francis Corazza
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19
Start date
2020-03-20
Primary completion
2020-11-23
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.